Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$9.19 - $11.6 $632,272 - $798,080
68,800 Added 70.28%
166,700 $1.67 Million
Q1 2024

May 15, 2024

BUY
$6.64 - $11.51 $593,616 - $1.03 Million
89,400 Added 1051.76%
97,900 $1.13 Million
Q4 2023

Feb 14, 2024

SELL
$6.49 - $9.2 $242,077 - $343,160
-37,300 Reduced 81.44%
8,500 $61,000
Q3 2023

Nov 14, 2023

BUY
$8.6 - $14.77 $197,800 - $339,710
23,000 Added 100.88%
45,800 $416,000
Q2 2023

Aug 14, 2023

SELL
$9.43 - $12.52 $612,950 - $813,800
-65,000 Reduced 74.03%
22,800 $277,000
Q1 2023

May 15, 2023

SELL
$12.43 - $22.73 $804,221 - $1.47 Million
-64,700 Reduced 42.43%
87,800 $1.09 Million
Q4 2022

Feb 14, 2023

SELL
$19.02 - $23.0 $937,686 - $1.13 Million
-49,300 Reduced 24.43%
152,500 $2.93 Million
Q3 2022

Nov 14, 2022

BUY
$17.38 - $25.72 $1.47 Million - $2.18 Million
84,700 Added 72.33%
201,800 $3.79 Million

Others Institutions Holding AHCO

About AdaptHealth Corp.


  • Ticker AHCO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,502,000
  • Market Cap $1.44B
  • Description
  • AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and s...
More about AHCO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.